The University of Southampton
University of Southampton Institutional Repository

Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood

Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood
Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood
Background: anti-tumour necrosis factor-α (anti-TNF) therapy use has risen in paediatric-onset inflammatory bowel disease (PIBD). Whether this has translated into preventing/delaying childhood surgery is uncertain. The Wessex PIBD cohort were analysed for trends in anti-TNF-therapy and surgery. Design: all patients diagnosed with PIBD within Wessex from 1997-2017 were assessed. Prevalence of anti-TNF-therapy and yearly surgery rates (resection and perianal) during childhood (<18 years) were analysed (Pearson’s correlation, multivariate regression, Fisher’s exact). Results: eight-hundred-and-twenty-five children were included (498 Crohn’s disease, 272 ulcerative colitis, 55 IBD-unclassified), mean age at diagnosis 13.6 years (1.6-17.6), 39.6% female. Prevalence of anti-TNF-treated patients increased from 5.1% to 27.1% (2007-2017), p=0.0001. Surgical resection-rate fell (7.1% to 1.5%, p=0.001), driven by a decrease in Crohn’s disease resections (8.9% to 2.3%, p=0.001). Perianal surgery and ulcerative colitis resection-rates were unchanged. Time from diagnosis to resection increased (1.6 to 2.8 years, p=0.028) but mean age at resection was unchanged. Patients undergoing resections during childhood were diagnosed at a younger age in the most recent five years (2007-2011=13.1 years, 2013-2017=11.9 years, p=0.014). Resection-rate in anti-TNF-therapy treated (16.1%) or untreated (12.2%) was no different (p=0.25). Patients started on anti-TNF-therapy <3 years post-diagnosis (11.6%) vs later (28.6%) had a reduction in resections, p=0.047. Anti-TNF-therapy prevalence was the only significant predictor of resection-rate using multivariate regression (p=0.011). Conclusion: the prevalence of anti-TNF-therapy increased significantly, alongside a decrease in surgical resection-rate. Patients diagnosed at younger ages still underwent surgery during childhood. Anti-TNF-therapy may reduce the need for surgical intervention in childhood, thereby influencing the natural history of PIBD.
0269-2813
398-407
Ashton, James J
03369017-99b5-40ae-9a43-14c98516f37d
Borca, Florina
31fc3965-6bcf-4fd6-85bc-8b0f99f62473
Mossotto, Enrico
a2a572db-3e95-41c6-94f6-f1b019594372
Coelho, Tracy, Antonio Francisco
83bbf944-8998-4f1f-ae32-ad2315bb5f8f
Batra, Akshay
822f891e-87ca-41d9-b68d-27c395e88809
Afzal, Nadeem A.
62505946-2503-42ba-9b02-85513bb3ec87
Phan, Hang Thi Thu
2811b94c-62b7-459d-9cc1-c88057008e3b
Stanton, Michael
eb3258f5-245b-454a-9556-9ef3d0ebb87d
Ennis, Sarah
7b57f188-9d91-4beb-b217-09856146f1e9
Beattie, R. Mark
55d81c7b-08c9-4f42-b6d3-245869badb71
Ashton, James J
03369017-99b5-40ae-9a43-14c98516f37d
Borca, Florina
31fc3965-6bcf-4fd6-85bc-8b0f99f62473
Mossotto, Enrico
a2a572db-3e95-41c6-94f6-f1b019594372
Coelho, Tracy, Antonio Francisco
83bbf944-8998-4f1f-ae32-ad2315bb5f8f
Batra, Akshay
822f891e-87ca-41d9-b68d-27c395e88809
Afzal, Nadeem A.
62505946-2503-42ba-9b02-85513bb3ec87
Phan, Hang Thi Thu
2811b94c-62b7-459d-9cc1-c88057008e3b
Stanton, Michael
eb3258f5-245b-454a-9556-9ef3d0ebb87d
Ennis, Sarah
7b57f188-9d91-4beb-b217-09856146f1e9
Beattie, R. Mark
55d81c7b-08c9-4f42-b6d3-245869badb71

Ashton, James J, Borca, Florina, Mossotto, Enrico, Coelho, Tracy, Antonio Francisco, Batra, Akshay, Afzal, Nadeem A., Phan, Hang Thi Thu, Stanton, Michael, Ennis, Sarah and Beattie, R. Mark (2019) Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood. Alimentary pharmacology & therapeutics, 49 (4), 398-407. (doi:10.1111/apt.15094).

Record type: Article

Abstract

Background: anti-tumour necrosis factor-α (anti-TNF) therapy use has risen in paediatric-onset inflammatory bowel disease (PIBD). Whether this has translated into preventing/delaying childhood surgery is uncertain. The Wessex PIBD cohort were analysed for trends in anti-TNF-therapy and surgery. Design: all patients diagnosed with PIBD within Wessex from 1997-2017 were assessed. Prevalence of anti-TNF-therapy and yearly surgery rates (resection and perianal) during childhood (<18 years) were analysed (Pearson’s correlation, multivariate regression, Fisher’s exact). Results: eight-hundred-and-twenty-five children were included (498 Crohn’s disease, 272 ulcerative colitis, 55 IBD-unclassified), mean age at diagnosis 13.6 years (1.6-17.6), 39.6% female. Prevalence of anti-TNF-treated patients increased from 5.1% to 27.1% (2007-2017), p=0.0001. Surgical resection-rate fell (7.1% to 1.5%, p=0.001), driven by a decrease in Crohn’s disease resections (8.9% to 2.3%, p=0.001). Perianal surgery and ulcerative colitis resection-rates were unchanged. Time from diagnosis to resection increased (1.6 to 2.8 years, p=0.028) but mean age at resection was unchanged. Patients undergoing resections during childhood were diagnosed at a younger age in the most recent five years (2007-2011=13.1 years, 2013-2017=11.9 years, p=0.014). Resection-rate in anti-TNF-therapy treated (16.1%) or untreated (12.2%) was no different (p=0.25). Patients started on anti-TNF-therapy <3 years post-diagnosis (11.6%) vs later (28.6%) had a reduction in resections, p=0.047. Anti-TNF-therapy prevalence was the only significant predictor of resection-rate using multivariate regression (p=0.011). Conclusion: the prevalence of anti-TNF-therapy increased significantly, alongside a decrease in surgical resection-rate. Patients diagnosed at younger ages still underwent surgery during childhood. Anti-TNF-therapy may reduce the need for surgical intervention in childhood, thereby influencing the natural history of PIBD.

Text
JJA RMB 20 11 18 Increased prevalence of anti-TNF therapy - Accepted Manuscript
Download (104kB)

More information

Accepted/In Press date: 22 November 2018
e-pub ahead of print date: 9 January 2019
Published date: 1 February 2019

Identifiers

Local EPrints ID: 426518
URI: http://eprints.soton.ac.uk/id/eprint/426518
ISSN: 0269-2813
PURE UUID: 29bc0ae7-fd28-4f1d-811b-8dfdeff57f81
ORCID for James J Ashton: ORCID iD orcid.org/0000-0003-0348-8198
ORCID for Sarah Ennis: ORCID iD orcid.org/0000-0003-2648-0869

Catalogue record

Date deposited: 29 Nov 2018 17:30
Last modified: 16 Mar 2024 07:21

Export record

Altmetrics

Contributors

Author: James J Ashton ORCID iD
Author: Florina Borca
Author: Enrico Mossotto
Author: Tracy, Antonio Francisco Coelho
Author: Akshay Batra
Author: Nadeem A. Afzal
Author: Hang Thi Thu Phan
Author: Michael Stanton
Author: Sarah Ennis ORCID iD
Author: R. Mark Beattie

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×